Correction to: Drugs (2022) 82:957–963 10.1007/s40265-022-01742-y
Page 960, Section 3.2.1 Tecovirimat, second-to-last sentence, which currently reads:
“The protocol also includes allowance for opening an oral capsule and mixing its content with liquid or soft food for pediatric patients weighing less than 13 kg”
Should more accurately read:
The protocol also includes allowance for opening an oral capsule and mixing its content with liquid or soft food for pediatric patients weighing less than 13 kg; however, patients weighing 3kg and above can receive more accurate intravenous dosing.
Additional references
Centers for Disease Control and Prevention (CDC). Clinical Guidance for the Treatment of Monkeypox. Updated August 3, 2022. https://www.cdc.gov/poxvirus/monkeypox/treatment.html. Accessed August 9, 2022.
Centers for Disease Control and Prevention (CDC). Clinical Considerations for Monkeypox in Children and Adolescents. Updated July 26, 2022. https://www.cdc.gov/poxvirus/monkeypox/clinicians/pediatric.html?ACSTrackingID=USCDC_1052- Accessed August 9, 2022.